{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"专注生命科学与医疗健康领域的投资机构。","sources":[],"related":[{"id":"f138535b-b046-46b6-b65d-9519a7ba8390","kind":"news","code":"f138535b-b046-46b6-b65d-9519a7ba8390","name":"Enveda Biosciences raises USD 311 million in Series E financing","nameBasis":"translated-title","summary":"On 2026-09-24, according to Xiniu Data, Enveda Biosciences completed Series E financing, raising USD 311 million. Investors were lead investor Catalio Capital Management, Durable Capital Partners, ICONIQ, Lightspeed and others. The company is a developer of AI natural product drugs.","description":"","country":null,"category":null,"originalName":"Enveda Biosciences完成E轮融资，融资金额3.11亿美元","eventDate":"2026-09-24T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T13:58:30.970Z","englishUpdatedAt":"2026-10-15T21:56:38.837Z","reviewedAt":"2026-10-15T21:56:38.837Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ef26800a86f832f09c886a3577e0372be2ba8049f66d9caff7fb8c8e16eb08e6","companyId":"709f4fb9-903d-4d79-b9c2-4f4c1f6f535b","foundedYear":null,"logoUrl":null,"path":"/news/f138535b-b046-46b6-b65d-9519a7ba8390"},{"id":"f95641aa-1529-4007-a257-5ead3f3aa3ba","kind":"news","code":"f95641aa-1529-4007-a257-5ead3f3aa3ba","name":"Enveda raises USD 311 million Series E","nameBasis":"translated-title","summary":"On 2026/9/23, Presspool reported that US AI drug discovery company Enveda had raised USD 311 million in Series E funding led by Catalio Capital Management.","description":"","country":null,"category":null,"originalName":"Enveda完成3.11亿美元E轮融资","eventDate":"2026-09-23T00:00:00.000Z","website":"https://presspool.ai/ai-startup-funding/week-of-2026-09-21","sourceUpdatedAt":"2026-10-10T18:51:56.327Z","englishUpdatedAt":"2026-10-16T00:25:50.049Z","reviewedAt":"2026-10-16T00:25:50.049Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2303bb7867eb6e03824c7d7be382538e007588c22a73212c9718e856e067e3d7","companyId":"709f4fb9-903d-4d79-b9c2-4f4c1f6f535b","foundedYear":null,"logoUrl":null,"path":"/news/f95641aa-1529-4007-a257-5ead3f3aa3ba"},{"id":"ee63690a-42fb-4857-8aef-c519c674f5d5","kind":"news","code":"ee63690a-42fb-4857-8aef-c519c674f5d5","name":"Flourish raises USD 500 million in Series A financing","nameBasis":"translated-title","summary":"On 2026-06-04, according to Xiniu Data, Flourish completed Series A financing, raising USD 500 million. Investors were Jeff Bezos, GV, Lux Capital, Catalio Capital Management. The company is a developer of neural AI synthetic intelligence systems.","description":"","country":null,"category":null,"originalName":"Flourish完成A轮融资，金额5亿美元","eventDate":"2026-06-04T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-16T19:46:30.439Z","englishUpdatedAt":"2026-10-18T08:52:13.964Z","reviewedAt":"2026-10-18T08:52:13.964Z","snapshotAt":"2026-10-18T08:51:49.337Z","sourceHash":"de694bfd8ca928c8e41877b5ff364ff0aa72ece573c0a1fa5c6b1ebb081f0509","companyId":"2e2b8da3-a737-4541-bbab-fdb22a069aab","foundedYear":null,"logoUrl":null,"path":"/news/ee63690a-42fb-4857-8aef-c519c674f5d5"},{"id":"1871556f-31bc-4eac-a1ce-c849ef34ad4d","kind":"news","code":"1871556f-31bc-4eac-a1ce-c849ef34ad4d","name":"Noetik raises USD 40 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Noetik完成4000万美元A轮融资","eventDate":"2024-08-30T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:18:21.819Z","englishUpdatedAt":"2026-10-15T17:19:59.273Z","reviewedAt":"2026-10-15T17:19:59.273Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"135290c884d1956dcf12ccb755ef547cd76118386dfb9dc262583dc9d03d9c56","companyId":"bc7f4dae-3ea0-40ba-9f0a-565dd7e11ef0","foundedYear":null,"logoUrl":null,"path":"/news/1871556f-31bc-4eac-a1ce-c849ef34ad4d"},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"news","code":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","name":"Superluminal Medicines raises USD 120 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成1.2亿美元A轮融资","eventDate":"2024-09-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T09:54:27.118Z","englishUpdatedAt":"2026-10-15T17:19:59.178Z","reviewedAt":"2026-10-15T17:19:59.178Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dad4fa4c64ac255cdb6fbb7b3cdf1ed0bfd304e3c8f6cb55d15dd5d95c6b3db7","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef"},{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"news","code":"22da73b7-c7eb-4a01-b246-146e4f248acc","name":"Superluminal Medicines raises USD 60 million in Series B financing","nameBasis":"translated-title","summary":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成B轮融资，融资金额6000万美元","eventDate":"2026-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:42:26.621Z","englishUpdatedAt":"2026-10-15T20:50:21.999Z","reviewedAt":"2026-10-15T20:50:21.999Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e8e7b1b012c19476316906130fd4ae28ebac9db6102a8c78bc6bf24e9a1a83b0","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc"}],"path":"/institutions/catalio-capital-management","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Catalio Capital Management is an investor based in the United States with 6 recorded investments in 4 companies.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/catalio-capital-management"}